<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00490893</url>
  </required_header>
  <id_info>
    <org_study_id>2005-003940-79</org_study_id>
    <nct_id>NCT00490893</nct_id>
  </id_info>
  <brief_title>Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir</brief_title>
  <official_title>Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoglycemia and unawareness of hypoglycemia are major problems of insulin therapy in
      patients with diabetes mellitus. The long acting insulin analogue Detemir has structural and
      physicochemical properties which differ from human insulin. The aim of the present study is
      to test whether this leads to altered hormone and symptom response during hypoglycemia.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hormone response to hypoglycemia (Glucagon)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Hormone response to hypoglycemia (glucagon) Symptom response to hypoglycemia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormone response to glucagon (epinephrine, growth hormne, cortisol)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormone response (epinephrine, growth hormone, cortisol) to hypoglycemia</measure>
  </secondary_outcome>
  <enrollment type="Actual">12</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Hypoglycemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Detemir</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects male or female

          -  Age 18-50 years

          -  Female subjects save contraception

          -  Ability to take part in the study

          -  Signed consent

        Exclusion Criteria:

          -  Chronic disease

          -  Acute disease during 4 weeks prior to the study

          -  Pregnancy

          -  Drug treatment other than hormonal contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Fritsche, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tübingen, Medical Department</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2007</study_first_submitted>
  <study_first_submitted_qc>June 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2007</study_first_posted>
  <last_update_submitted>June 22, 2007</last_update_submitted>
  <last_update_submitted_qc>June 22, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2007</last_update_posted>
  <keyword>counterregulation</keyword>
  <keyword>hypoglycemia unawareness</keyword>
  <keyword>insulin therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Detemir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

